Everything You Need to Know About Hollywood's Latest Weight-Loss Drugs
Description
Off-label use of new(ish) diabetes medications — Ozempic, Wegovy, Mounjaro, and other GLP-1 antagonists— have dominated the wellness news cycle & celebrity gossip sites, and flooded social media conversations about and around weight-loss in 2022. So, what are they, how do they work, what are the pros vs. cons of using them, and what else do we need to know about the safety, efficacy, and risks of these drugs?
Joining me to discuss this topic in depth is Registered Dietitian Nutritionist Lauren Harris-Pincus, author, prediabetes & diabetes expert, and weight-management specialist.
We cover:
- The mechanism of action of GLP-1 antagonists and how they work for weight-loss Why these medications have skyrocketed in popularity for weight-loss (despite the financial cost)
- The impact of social media marketing on the pharmaceutical and healthcare industry What dietitians and obesity experts should know about working with patients who have overweight/obesity
- Side effects of these medications: What anyone considering taking these drugs should know and the questions to ask your HCP
- Future predictions & trend forecasting about celebrity use of weight-loss medications and the impact this may have on diet culture
Thanks for listening to The Business of Wellness with Jaclyn London, MS, RD.
- Support this podcast by following the show; rating us 5-stars, & leaving a review
- Follow me on social: instagram, tiktok, twitter & youtube Learn more & stay in touch, here
- Check out my audiobook
*Advice provided on this podcast should not replace medical advice provided by your physician.
United States
